Creso Pharma ltd

CPH.AX | CPH.AX

Creso was created to bring pharmaceutical expertise and methodological rigour to the world of cannabis and deliver quality products to people and animals everywhere. Founded by a team of highly-experienced pharmaceutical executives, Creso set out to leverage cutting edge science and research to develop, register, and commercialize innovative cannabis and hemp derived products.

Related content

Investing Ideas |

The HighBrid Lab blends complementary therapies amid rising investor interest

Creso Pharma is joining forces with long-established psychedelics business Red Light Holland Corp.

Investing Ideas |

Why Creso Pharma is Set to Be First-Mover in New Corner of Projected $16 Trillion Market

Creso Pharma's revolutionary approach to treating the $16 trillion mental health problem.

Investing Ideas |

This firm is taking a diversified approach to two novel sectors helping millions worldwide...

Creso Pharma are entering a brand-new booming market as it rides the second green wave.

News |

Billionaire John Hancock invests in Creso Pharma as share placing demand soars

Creso Pharma's latest share placing exceeded expectations with an upsized placement to $18m. Major investors include Australian Billionaire John...

Press Releases |

Agreement to acquire established Canadian psychedelics company Halucenex Life Sciences Inc.

Creso Pharma has signed an agreement to acquire Halucenex Life Sciences, an established psychedelics company focused on developing treatments...

Press Releases |

LOI Secured With ImpACTIVE To Drive Growth In North America And Europe

Press Releases |

Creso signs non-binding LOI to conditionally enter US market with established partner

Creso Pharma is pleased to advise that it has executed a non-binding letter of intent (“LOI”) with leading CBD and plant-based remedies provider...

Investing Ideas |

This Company Has Developed a Range of Market-Leading Complementary Feed Products Specifically Formulated For Pets...

Press Releases |

Creso’s wholly owned Canadian subsidiary Mernova Medicinal Inc. secures four new purchase orders (POs) totalling C$494,131 (A$502,1991)

Press Releases |

Distribution Agreement Secured for Innovative Hemp Derived Therapeutic Products in Pakistan, Philippines and Other New Markets

Investing Ideas |

This Company Is Maximizing its Growth in an Emerging Sector With a Three-Pillar Strategy

Press Releases |

Creso Pharma welcomes OTC sale of CBD products in Australia

Press Releases |

Mernova Medicinal Inc. secures licensing and supply agreement with Khalifa Kush Enterprises

Sign up for VTM Updates

Form submitted successfully!

VTM Exclusive Reports

Crypto Corner

Learn your NFTs from your BTCs